
Overview
Labs212 is a company that manufactures dietary supplements, including products like Homocysteine Support, Adeno B-12, Methyl B-12, and various vitamin complexes aimed at supporting the immune and nervous systems. Their offerings also include natural ingredients such as Beta Glucan and L-Lysine with Zinc, as well as formulations for joint and digestive health. Each product is developed with certified raw materials and undergoes testing for quality assurance.
Financials
Revenue history (in k)
Filing timeliness
3 of 6 financial statements were filed late (the longest delay 365 days for 2021).
- 202523/09/2026
- 202431/03/2025
- 202327/06/2024
- 202216/07/2023
- 202115/07/2023
- 202012/10/2021
Data and insights are generated automatically from financial statements – they may contain errors and are neither a credit assessment nor business advice.
Statistics
How the company ranks by revenue within its industry, city, voivodeship and across Poland in 2025.
Results vs industry
Industry
Offer
Websites
- labs212.comSuplementy diety – LABS212®. Twoja inspiracja do zdrowiaWooCommerceWordPressGoogle Tag ManagerMeta PixelYoast SEOWWPML
Trademarks
The company holds 9 active trademarks registered with the Polish Patent Office. 10 marks have expired or were not registered. The first mark was filed in 2021.
| Mark | Protected until | |
|---|---|---|
| FeroMax (word) | Nov 29, 2034 | |
| Hepa Spectrum (word) | Nov 19, 2034 | |
| Bind Formula (word) | Nov 19, 2034 | |
| Thyro Spectrum (word) | Nov 19, 2034 | |
| CurcuVITA (word) | Jan 10, 2032 |
Authorized Representatives
Manner of representation
The following is authorized to make declarations of will on behalf of the company: A) in the case of a one-person management board – the sole member of the management board acting independently; B) in the case of a two-member management board – each member of the management board acting independently.
Ownership
| Owner | Shares | Share value | Stake |
|---|---|---|---|
Beata Rogalska age 53 | 1,400 | $18,908.70 | 70% |
Jacek Saczuk age 60 | 600 | $8,103.73 | 30% |
Beneficial owners
| Person | Rights |
|---|---|
Bank accounts
Registered as a VAT taxpayer on 2021-06-02.
13 1020 5024 0000 1602 0174 7138
39 1020 1055 0000 9502 0516 9992
34 1020 1055 0000 9702 0516 9984
Debt
No entries in the National Debtors Register (KRZ).
Public aid
| Grant date | Purpose | Gross amount | Granting body | |
|---|---|---|---|---|
| Jul 1, 2025 | De minimis aid (in accordance with Commission Regulation 2023/2831) | $1,803$1,803 | Prezes Zakładu Ubezpieczeń Społecznych | |
| Feb 21, 2025 | De minimis aid (in accordance with Commission Regulation 2023/2831) | $106.7K$106,730 | Marszałek Województwa Łódzkiego | |
| Jun 24, 2022 | De minimis aid (in accordance with Commission Regulation No 1407/2013 or earlier) | $2,411$2,411 | Prezes Banku Gospodarstwa Krajowego |
European Funds
| Start | Project | EU co-financing | Programme | |
|---|---|---|---|---|
| 2024-07-01 | Export development at LABS212. | $77,299$77,299 | European Funds for Łódzkie 2021-2027 |
Regulatory authorisations
| Authority | Type | Status | |
|---|---|---|---|
| BDO register entry | Active |
Competitors
| Name | Revenue | Website | ||
|---|---|---|---|---|
| Bioticom sp. z o.o. | $2,659,090.32 | bioticom.pl | ||
| Akuna Polska sp. z o.o. | $2,025,454.04 | akuna.pl | ||
| Puromedica sp. z o.o. | $1,800,338.28 | puromedica.com | ||
| Noblepharma sp. z o.o. | $1,695,021.71 | noblepharma.pl | ||
| Bionatur sp. z o.o. + limited partnership | $1,192,779.68 | bionatur.pl | ||
| NERR Pharma sp. z o.o. | $1,125,302.01 | nerrpharma.com | ||
| Sanlife sp. z o.o. | $863,647.72 | sanlife.pl | ||
| Hepatica sp. z o.o. | $636,973.96 | hepatica.pl | ||
| Medso sp. z o.o. | $414,558.93 | medso.pl | ||
| Pharmacreator Produkcja sp. z o.o. | $405,607.25 | pharmovit.pl |
Change history
| Date | Event | |
|---|---|---|
| 2021-11-02 | Share capital increase (35,000.00 PLN → 100,000.00 PLN) | |
| 2021-05-17 | Address change (Ul. Szeroka 21/2, 87-100, Toruń → Ul. Henryka Sienkiewicza 85/87/8, 90-057, Łódź) | |
| 2020-04-27 | Entered in the register |
FAQ
Last updated: 2026-09-25